CN100446761C - 黄芩提取物在制备抗食道癌药物中的应用 - Google Patents
黄芩提取物在制备抗食道癌药物中的应用 Download PDFInfo
- Publication number
- CN100446761C CN100446761C CNB031099335A CN03109933A CN100446761C CN 100446761 C CN100446761 C CN 100446761C CN B031099335 A CNB031099335 A CN B031099335A CN 03109933 A CN03109933 A CN 03109933A CN 100446761 C CN100446761 C CN 100446761C
- Authority
- CN
- China
- Prior art keywords
- baicalin
- medicine
- cell
- cancer
- esophageal cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031099335A CN100446761C (zh) | 2003-04-08 | 2003-04-08 | 黄芩提取物在制备抗食道癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031099335A CN100446761C (zh) | 2003-04-08 | 2003-04-08 | 黄芩提取物在制备抗食道癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1442134A CN1442134A (zh) | 2003-09-17 |
CN100446761C true CN100446761C (zh) | 2008-12-31 |
Family
ID=27796768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031099335A Expired - Fee Related CN100446761C (zh) | 2003-04-08 | 2003-04-08 | 黄芩提取物在制备抗食道癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100446761C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1879615B (zh) * | 2005-01-20 | 2010-05-26 | 上海格鲁奥丽生物医药技术有限公司 | 抗肿瘤的协同药物组合物 |
EP1849467A4 (en) * | 2005-02-01 | 2008-08-20 | Shanghai Gloriayx Biopharmaceu | SYNERGIC PHARMACEUTICAL PREPARATION CONTAINING BAICALEIN AND BAICALIN AND INTENDED FOR INHIBITION OF A TUMOR |
CN110115712A (zh) * | 2019-07-04 | 2019-08-13 | 兰州大学 | 一种同时激活氧化磷酸化通路和抑制糖酵解途径的激活剂及其应用 |
-
2003
- 2003-04-08 CN CNB031099335A patent/CN100446761C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1442134A (zh) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110123809A (zh) | 5-甲基-二氢苯并呋喃-咪唑盐类化合物在制药中的应用 | |
CN100446761C (zh) | 黄芩提取物在制备抗食道癌药物中的应用 | |
CN113143913A (zh) | 一种桉烷型倍半萜类化合物在制备抗胰腺癌药物中的应用 | |
CN105670998B (zh) | 一种钙化癌细胞的方法 | |
CN101948473B (zh) | 新的neo-克罗烷型二萜化合物及其应用 | |
CN100534493C (zh) | 一种新的抗肿瘤复方药物 | |
CN1276751C (zh) | 黄芩提取物在制备抗胃癌药物中的应用 | |
CN113181166B (zh) | 莪术烯醇在制备抗肺癌药物中的应用 | |
CN102858359B (zh) | 一种含有醇溶性且非水溶性甘草提取物的药物组合物,及其药物制剂、制药用途、治疗方法和制备方法 | |
CN107496428A (zh) | 毛蕊异黄酮衍生物在制备促进内皮细胞增殖药物中的应用 | |
CN105534966A (zh) | γ-氨基丁酸作为增强化疗敏感性的活性成分的应用 | |
CN1264507C (zh) | 黄芩提取物在制备抗鼻咽癌药物中的应用 | |
CN105560302B (zh) | 老鹳草水提物在制备抗血管生成类药物中的应用 | |
CN113876840A (zh) | 苦荞黄酮在制备治疗胰腺癌药物中的应用 | |
CN100544736C (zh) | 一种增强免疫力的药物组合物及制备方法 | |
CN100446802C (zh) | 预防肿瘤转移的天然药物 | |
CN108452240B (zh) | 一种抗肿瘤的中药组合物及其应用 | |
CN106265619A (zh) | Dfmo或dfmo和姜提取物在制备食管癌和肝癌的预防及临床治疗的药物中的应用 | |
CN107468684B (zh) | 鞣花酸及与雷公藤红素协同在制备抗肺癌药物中的应用 | |
CN111228319A (zh) | 鸦胆子提取物及其制备方法和在防治乳腺癌方面的应用 | |
CN102008493A (zh) | 人参二醇皂苷在制备与糖皮质激素受体结合药物中的应用 | |
CN105477068B (zh) | 一种桑枝叶活性部位的制备方法及其应用 | |
CN100430064C (zh) | 黄芩甙在制备抑制血管生成药物中的应用 | |
CN113368090B (zh) | 3,4-裂环环阿屯烷型四环三萜化合物或其药学上可接受的盐在制备抗癌药物中的用途 | |
CN102028698A (zh) | 一种治疗结肠癌的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Assignor: Hangzhou Huadong Medicine Group Biological Engineering Research Institute Co., Ltd. Contract record no.: 2011330000095 Denomination of invention: Application of scutellaria root extract in preparation of anti esophageal cancer medicine Granted publication date: 20081231 License type: Exclusive License Open date: 20030917 Record date: 20110314 |
|
C56 | Change in the name or address of the patentee |
Owner name: NEW DRUG RESEARCH INSTITUTE CO., LTD. OF HANGZHOU Free format text: FORMER NAME: BIOENGINEERING INST. CO., LTD., HANGZHOU EAST-CHINA MEDICINE GROUP |
|
CP01 | Change in the name or title of a patent holder |
Address after: Hangzhou City, Zhejiang province 310011 Moganshan Road No. 866 Patentee after: HANGZHOU HUADONG MEDICINE GROUP NEW MEDICINE RESEARCH INSTITUTE CO., LTD. Address before: Hangzhou City, Zhejiang province 310011 Moganshan Road No. 866 Patentee before: Hangzhou Huadong Medicine Group Biological Engineering Research Institute Co., Ltd. |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Assignor: Hangzhou Huadong Medicine Group Biological Engineering Research Institute Co., Ltd. Contract record no.: 2011330000095 Date of cancellation: 20140113 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081231 Termination date: 20150408 |
|
EXPY | Termination of patent right or utility model |